<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Albireo Pharma, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Our parent company, Albireo Pharma, Inc., is located in Boston, Massachusetts and our key operating subsidiary, Albireo AB, is located in Gothenburg, Sweden. We were spun out from AstraZeneca in 2008. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Ron Cooper
    • FOUNDED
      2003
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    GlycoMimetics, Inc.

    GlycoMimetics, Inc.

    At GlycoMimetics, we are committed to helping to make a difference in the lives of...

    At GlycoMimetics, we are committed to helping t...

    Filing Type:    PU
    Assertio Therapeutics, Inc.

    Assertio Therapeutics, Inc.

    Assertio Therapeutics is committed to providing responsible solutions to advance p...

    Assertio Therapeutics is committed to providing...

    Filing Type:    PU
    Arcturus Therapeutics Holdings Inc.

    Arcturus Therapeutics Holdings Inc.

    Arcturus Therapeutics is developing portfolio of RNA therapeutics for treatment of...

    Arcturus Therapeutics is developing portfolio o...

    Filing Type:    PU
    WinSanTor, Inc.

    WinSanTor, Inc.

    WinSanTor’s mission is simple-develop a drug that works. We recognize that there a...

    WinSanTor’s mission is simple-develop a drug th...

    Amount Raised:    $572,649.00
    Fundraising Status:    EC
    Filing Type:    CF
    Menlo Therapeutics Inc.

    Menlo Therapeutics Inc.

    We are a late stage biopharmaceutical company focused on the development and comme...

    We are a late stage biopharmaceutical company f...

    Filing Type:    PU
    Kamada Ltd.

    Kamada Ltd.

    Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indicatio...

    Kamada Ltd. is focused on plasma-derived protei...

    Filing Type:    PU
    Cyclerion Therapeutics, Inc.

    Cyclerion Therapeutics, Inc.

    Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing th...

    Cyclerion Therapeutics is a clinical-stage biop...

    Filing Type:    PU
    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU
    Conatus Pharmaceuticals Inc.

    Conatus Pharmaceuticals Inc.

    Conatus Pharmaceuticals is a biotechnology company focused on the development and ...

    Conatus Pharmaceuticals is a biotechnology comp...

    Filing Type:    PU
    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...

    Seres Therapeutics, Inc. is a microbiome therap...

    Filing Type:    PU
    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicat...

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI...

    Filing Type:    PU
    Novan, Inc.

    Novan, Inc.

    Novan, Inc. is a clinical development-stage biotechnology company focused on lever...

    Novan, Inc. is a clinical development-stage bio...

    Filing Type:    PU
    ©2023 National Investor Network. All Rights Reserved.